Search

Search Constraints

You searched for: Author/Creator Fernández-Clotet, A

Search Results

1. DOP05 Single-cell RNAseq temporal analysis of ulcerative colitis patients undergoing tofacitinib treatment reveals a shift in myeloid cells towards pro-inflammatory phenotypes in refractory patients. (30th January 2023)

2. DOP44 Efficacy and safety of tacrolimus in ulcerative colitis: a nationwide, multi-centre study from GETECCU. (25th January 2019)

3. DOP52 Safety of Inflammatory Bowel Disease drugs during pregnancy and breastfeeding: Mothers and babies' outcomes (DUMBO registry). (27th May 2021)

4. DOP78 Comparative study of the effectiveness of vedolizumab versus ustekinumab after anti-TNF failure (VERSUS-CD). (21st January 2022)

5. OP29 Tofacitinib in ulcerative colitis: Real-world evidence from Eneida Registry. (15th January 2020)

6. P104 Inflammatory complications of the pouch, and therapetic requirements after colectomy in patients with ulcerative colitis. Results from the RESERVO Study of GETECCU. (27th May 2021)

7. P223 Efficacy and safety of tacrolimus in Crohn's disease: a nationwide, multi-centric study from GETECCU. (25th January 2019)

8. P293 Prognosis of small intestinal ulcers (SIUs) on capsule endoscopy when magnetic resonance enterography is normal. (25th January 2019)

9. P319 Impact of biological agents on postoperative complications in inflammatory bowel disease: a multicentre study of GETECCU. (27th May 2021)

10. P357 Long-term outcomes of biologic therapy in Crohn's disease complicated with internal fistulizing disease: BIOSCOPE study from GETECCU. (27th May 2021)